Litigation Details for Bristol-Myers Squibb Company v. Handa Oncology, LLC (N.D. Cal. 2022)
✉ Email this page to a colleague
Bristol-Myers Squibb Company v. Handa Oncology, LLC (N.D. Cal. 2022)
Docket | ⤷ Sign Up | Date Filed | 2022-11-07 |
Court | District Court, N.D. California | Date Terminated | |
Cause | 35:271 Patent Infringement | Assigned To | |
Jury Demand | Referred To | ||
Patents | 6,596,746; 7,491,725; 8,680,103 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Bristol-Myers Squibb Company v. Handa Oncology, LLC
Details for Bristol-Myers Squibb Company v. Handa Oncology, LLC (N.D. Cal. 2022)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2023-06-05 | 38 | inhibitors:…” US 6,596,746 Consideration, Pharmaceutical Research (1995) 945– (“the ’746 patent”) at 2:2… disorders see, U.S. Pat. No. 6,596,746 (the ’746 Language 1137 (4th… ’725 patent, 07-29-2005 Specification at 31. E.g., ’103 Patent at Abstract…the ’725 patent, it is to be understood that the corresponding text from the ’103 patent is also …EVIDENCE: BMS06005725–831 (E.g., U.S. Patent 7,973,045 (“’045 Patent”) col. 55, ll. 19 – col. 76, ll. 13 | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |